AUSTIN, Texas--(BUSINESS WIRE)--EverlyWell, the next-generation healthcare testing platform, announced today that it has completed another round of funding -- bringing total funding to $5 million since the company’s inception less than two years ago. The new round was led by NextGen Venture Partners with Jack Novak, SoGal Ventures, Full Tilt Capital, and other venture capital funds also contributing. Founder and CEO Julia Cheek now joins the short list of female founders who have raised venture capital funding.
As one of the fastest-growing consumer healthcare startups in recent history, EverlyWell reached millions in sales less than a year after its beta launch -- while also delivering profitable unit economics. The company now has 15 full-time employees and thousands of customers in 46 states. This most recent round of funding will help the company expand its suite of tests, hire key leadership positions, launch new partnerships, and enhance product features this year.
“Our vision is to make healthcare services like lab testing accessible, simple, and meaningful for consumers. This additional funding enables us to accelerate our growth even more,” says Julia Cheek, CEO and Founder of EverlyWell. “We’re leading a major shift in the consumer health marketplace by bringing the lab to consumers' doorsteps, and we are moving quickly to expand our channels, launch innovative tests, and deliver a world-class customer experience.”
Today’s funding announcement comes at time when women-led companies account for a very small proportion of total digital health funding (of the digital health companies funded in 2016, only 9% had a woman CEO) -- not to mention overall venture capital investments. EverlyWell’s CEO and founder, Julia Cheek, is proud to join that short list of female founders who are leading the charge towards closing the venture capital funding gender gap, specifically in the digital health space.
“Amid uncertainty in the healthcare landscape, people are taking control and becoming proactive and informed healthcare consumers. Julia Cheek and EverlyWell have reimagined the lab testing experience - providing customers an affordable, convenient, personalized solution - without having to navigate a complicated healthcare system,” says EverlyWell investor Lisa Cuesta, Vice President at NextGen Venture Partners. “EverlyWell distinguishes itself as a reliable brand that customers can trust to deliver high-quality, consistent service so they can feel more confident making decisions about their health and wellness.”
EverlyWell provides at-home lab testing kits with beautifully redesigned results. They are the only company offering a suite of regulatory-compliant, physician-mediated lab tests that can be ordered and collected by consumers without leaving home. The platform currently offers 12 different at-home lab tests including sexual health, thyroid, metabolism, men’s health, and breast milk DHA testing, which the company is the exclusive provider of in the U.S.
Founded in 2015, EverlyWell offers a suite of regulatory-compliant, physician-reviewed, at-home lab tests, without a lab visit or an in-person doctor referral. The platform empowers consumers to order, self-collect, and understand their own physician-mediated lab tests with the goal of improving health and reducing risk of disease. Headquartered in Austin, TX. Find out more at EverlyWell.com, and follow us on Facebook or Twitter.